(Q33373879)

English

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

Matthew R Sydes

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Pancras C.W. Hogendoorn

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Ian J Lewis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Marianne A Nooij

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Jeremy Whelan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Robert Grimer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Muhammad A Memon

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Simon Weeden

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Barbara M Uscinska

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Martine van Glabbeke

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Anne Kirkpatrick

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Esther I Hauben

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Alan W Craft

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Antonie H M Taminiau

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

MRC BO06 and EORTC 80931 collaborators

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

European Osteosarcoma Intergroup

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

0 references

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

99

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

112-128

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227995%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Surgical options for children with osteosarcoma

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Dose-dense chemotherapy in breast cancer and lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Theoretical concepts and the emerging role of taxanes in adjuvant therapy

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Methotrexate serum concentration and histological response to multiagent primary chemotherapy for osteosarcoma of the limbs

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK015

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33373879&oldid=1950589637"